Nuvalent Newsroom

J.P. Morgan Reaffirms Their Buy Rating on Nuvalent (NUVL)

TipRanksNov 21 20:08

Nuvalent's Promising ALK and ROS1 Programs Drive Buy Rating Amid Strong Financial Position and Upcoming Trials

TipRanksNov 14 15:37

BMO Capital Maintains Nuvalent(NUVL.US) With Buy Rating, Raises Target Price to $134

Futu NewsNov 13 21:36

TD Cowen Maintains Nuvalent(NUVL.US) With Buy Rating

Futu NewsNov 13 21:36

Stifel Maintains Nuvalent(NUVL.US) With Buy Rating, Cuts Target Price to $132

Futu NewsNov 13 21:36

Nuvalent Is Maintained at Outperform by BMO Capital

Dow JonesNov 13 21:14

A Quick Look at Today's Ratings for Nuvalent(NUVL.US), With a Forecast Between $100 to $134

Futu NewsNov 13 21:06

Nuvalent Analyst Ratings

BenzingaNov 13 21:04

BMO Capital Maintains Outperform on Nuvalent, Raises Price Target to $134

BenzingaNov 13 21:04

Barclays Remains a Buy on Nuvalent (NUVL)

TipRanksNov 13 18:16

Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Nuvalent (NUVL)

TipRanksNov 13 08:42

Nuvalent: Strategic Progress and Pipeline Advancements Solidify Buy Rating

TipRanksNov 13 00:08

Nuvalent Initiated at Neutral by UBS

Dow JonesOct 24 20:05

UBS Initiates Coverage On Nuvalent With Neutral Rating, Announces Price Target of $100

BenzingaOct 24 19:57

Nuvalent Is Maintained at Overweight by JP Morgan

Dow JonesOct 5 02:35

Nuvalent Analyst Ratings

BenzingaOct 5 02:27

J.P. Morgan Maintains Nuvalent(NUVL.US) With Buy Rating, Raises Target Price to $125

Futu NewsOct 4 19:31

A Quick Look at Today's Ratings for Nuvalent(NUVL.US), With a Forecast Between $100 to $135

Futu NewsSep 17 21:00

Nuvalent Price Target Raised to $132.00/Share From $102.00 by BMO Capital

Dow JonesSep 16 21:04

A Quick Look at Today's Ratings for Nuvalent(NUVL.US), With a Forecast Between $100 to $135

Futu NewsSep 16 21:00